About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Contact
X
LinkedIn
Contact Us

The Latest

Newsroom

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Recent Posts

5/11/2022
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
Announcements
3/28/2022
BigHat Biosciences Completes Its Acquisition of Frugi Biotechnology
Announcements
3/8/2022
Luminaries Rob Chess, Mark Pegram and Michael Jewett join BigHat’s Advisory Board
Announcements
3/1/2022
BigHat in Pharma’s Almanac Q1 2022 Issue
Announcements
2/23/2022
BigHat’s CEO and CSO on BIOS Builders podcast
Announcements
1/13/2022
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference
Announcements
1/11/2022
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
Announcements
12/22/2021
BigHat Holiday Memo 2021
Announcements
10/30/2021
BigHat’s New Facility
Announcements
10/27/2021
BigHat Wins “2021 Therapeutics Innovation of the Year” from BioTech Breakthrough
Announcements
10/12/2021
BigHat selected as the winner at the UCSF Health Awards
Announcements
8/18/2021
BigHat’s CSO on Moneyball Medicine podcast
Announcements
Contact
1900 Alameda de las Pulgas
Suite 400
San Mateo, CA 94403
Navigation
About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Social
X
LinkedIn
© BigHat Bio 2026